NCT03300622

Brief Summary

Lung cancer is the leading cause of death in men and the second in women with a 5 year survival in Europe of less than 15%. One of the methods most used for its treatment is pulmonary resection. The objective of this study is to analyze the clinical profile presented to patients after pulmonary resection.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Sep 2017

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2017

Completed
19 days until next milestone

First Submitted

Initial submission to the registry

September 20, 2017

Completed
13 days until next milestone

First Posted

Study publicly available on registry

October 3, 2017

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2018

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2018

Completed
Last Updated

October 3, 2017

Status Verified

September 1, 2017

Enrollment Period

9 months

First QC Date

September 20, 2017

Last Update Submit

September 27, 2017

Conditions

Thoracic Surgery

Outcome Measures

Primary Outcomes (1)

  • Strength in upper and lower limbs

    Changes from baseline to postintervention during hospital stay in lower and upper limbs strength. The quadriceps and the hand-grip strength is assessed using a portable dynamometer with a standard protocol allowing three attempts on each side.

    Baseline, up to 1 month

Secondary Outcomes (1)

  • Exercise capacity

    Baseline, up to 1 month

Other Outcomes (10)

  • Mood

    Baseline, up to 1 month

  • Fatigue

    Baseline, up to 1 month

  • Changes in quality of sleep

    Baseline, up to 1 month

  • +7 more other outcomes

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Men and / or women of legal age who are admitted for lung resection, with the approval of the physician responsible, and who sign the informed consent

You may qualify if:

  • Patient admitted for lung resection and who sign the informed consent

You may not qualify if:

  • Patients who did not agree to sign informed consent and those who presented other types of problems to be able to adequately carry out the assessment, such as not handling the language.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Physical Therapy

Granada, 18071, Spain

RECRUITING

Study Officials

  • Marie Carmen Valenza, PT, PhD

    Universidad de Granada

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Marie Carmen Valenza, PhD

CONTACT

958248035cvalenza@ugr.es

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

September 20, 2017

First Posted

October 3, 2017

Study Start

September 1, 2017

Primary Completion

June 1, 2018

Study Completion

July 1, 2018

Last Updated

October 3, 2017

Record last verified: 2017-09

Locations

ES(1)